PRRSV : only one MLV per herd !
In Europe, modified live vaccines (MLV) are commonly used to control porcine reproductive and respiratory syndrome virus (PRRSV) infection. However, they have been associated with safety issues such as reversion to virulence induced by mutation and/or recombination. On a French pig farm, we identified a field recombinant strain derived from two PRRSV-1 MLV. Estimation of transmission parameters revealed fastest transmission and longest duration of infectiousness for pigs exposed to the recombinant strain.